Morgan Stanley’s NexImmune, Inc. Common Stock NEXI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-34
| Closed | -$76 | – | 8019 |
|
2023
Q4 | $76 | Buy |
34
+16
| +89% | +$36 | ﹤0.01% | 7548 |
|
2023
Q3 | $94 | Buy |
+18
| New | +$94 | ﹤0.01% | 7447 |
|
2023
Q1 | – | Sell |
-33
| Closed | -$199 | – | 7862 |
|
2022
Q4 | $199 | Sell |
33
-104
| -76% | -$627 | ﹤0.01% | 7645 |
|
2022
Q3 | $2K | Sell |
137
-533
| -80% | -$7.78K | ﹤0.01% | 7502 |
|
2022
Q2 | $27K | Buy |
670
+516
| +335% | +$20.8K | ﹤0.01% | 6878 |
|
2022
Q1 | $16K | Sell |
154
-1,354
| -90% | -$141K | ﹤0.01% | 7246 |
|
2021
Q4 | $174K | Buy |
1,508
+1,415
| +1,522% | +$163K | ﹤0.01% | 6139 |
|
2021
Q3 | $35K | Sell |
93
-1,092
| -92% | -$411K | ﹤0.01% | 6875 |
|
2021
Q2 | $484K | Buy |
1,185
+153
| +15% | +$62.5K | ﹤0.01% | 5540 |
|
2021
Q1 | $493K | Buy |
+1,032
| New | +$493K | ﹤0.01% | 5158 |
|